Business Description
Edwards Lifesciences Corp
NAICS : 339113
SIC : 3842
ISIN : BRE1WLBDR000
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.29 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.38 | |||||
Interest Coverage | 102.74 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 10.67 | |||||
Beneish M-Score | -1.21 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.4 | |||||
3-Year EBITDA Growth Rate | 20.6 | |||||
3-Year EPS without NRI Growth Rate | 10.5 | |||||
3-Year FCF Growth Rate | 0.3 | |||||
3-Year Book Growth Rate | 14.7 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 79.43 | |||||
9-Day RSI | 77.37 | |||||
14-Day RSI | 74.53 | |||||
6-1 Month Momentum % | -16.75 | |||||
12-1 Month Momentum % | 11.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.46 | |||||
Quick Ratio | 2.89 | |||||
Cash Ratio | 2.29 | |||||
Days Inventory | 254.81 | |||||
Days Sales Outstanding | 42.33 | |||||
Days Payable | 44.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 3.4 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.97 | |||||
Operating Margin % | 27.4 | |||||
Net Margin % | 63.02 | |||||
FCF Margin % | 7.99 | |||||
ROE % | 55.59 | |||||
ROA % | 40.35 | |||||
ROIC % | 22.84 | |||||
ROC (Joel Greenblatt) % | 60.77 | |||||
ROCE % | 18.91 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.9 | |||||
Forward PE Ratio | 32.18 | |||||
PE Ratio without NRI | 28.29 | |||||
Shiller PE Ratio | 32.97 | |||||
Price-to-Owner-Earnings | 12.05 | |||||
PEG Ratio | 1.61 | |||||
PS Ratio | 6.92 | |||||
PB Ratio | 4.66 | |||||
Price-to-Tangible-Book | 6.38 | |||||
Price-to-Free-Cash-Flow | 92.68 | |||||
Price-to-Operating-Cash-Flow | 56.41 | |||||
EV-to-EBIT | 24.08 | |||||
EV-to-Forward-EBIT | 25.73 | |||||
EV-to-EBITDA | 22.13 | |||||
EV-to-Forward-EBITDA | 23.1 | |||||
EV-to-Revenue | 6.18 | |||||
EV-to-Forward-Revenue | 6.91 | |||||
EV-to-FCF | 82.53 | |||||
Price-to-Projected-FCF | 2.19 | |||||
Price-to-DCF (Earnings Based) | 1.18 | |||||
Price-to-DCF (FCF Based) | 7.5 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.02 | |||||
Price-to-Graham-Number | 2.83 | |||||
Price-to-Net-Current-Asset-Value | 13.49 | |||||
Price-to-Net-Cash | 43.58 | |||||
Earnings Yield (Greenblatt) % | 4.15 | |||||
FCF Yield % | 1.1 | |||||
Forward Rate of Return (Yacktman) % | 15.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Edwards Lifesciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 34,003.136 | ||
EPS (TTM) (R$) | 9.392 | ||
Beta | -0.18 | ||
Volatility % | 46.69 | ||
14-Day RSI | 74.53 | ||
14-Day ATR (R$) | 1.265237 | ||
20-Day SMA (R$) | 109.5645 | ||
12-1 Month Momentum % | 11.22 | ||
52-Week Range (R$) | 85 - 129.61 | ||
Shares Outstanding (Mil) | 2,359.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Edwards Lifesciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Edwards Lifesciences Corp Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
Edwards Lifesciences Corp Frequently Asked Questions
What is Edwards Lifesciences Corp(BSP:E1WL34)'s stock price today?
When is next earnings date of Edwards Lifesciences Corp(BSP:E1WL34)?
Does Edwards Lifesciences Corp(BSP:E1WL34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |